Join the club for FREE to access the whole archive and other member benefits.

Kate Goodwin

Life Sciences Writer at BioSpace

Kate Goodwin hails from a background primarily in marketing. A passion for health sciences and writing led her to the biopharma news world, and she's never looked back. She's been writing for BioSpace for more than two years with a focus on cutting edge research, Alzheimer's disease and pediatrics. Her free time is filled by her husband, children, Beagles, books, crochet and creative writing. 

Passionate writer currently focused on the life sciences industry. Looking to broaden base of connections on LinkedIn, particularly in the biopharma world, for future articles and expert opinions. 


Visit website: https://www.biospace.com/staticpages/10284/contributors/

 kate-goodwin-bb68401b7

 TheKateGoodwin

See also

Biospace

Digital hub for life science news and careers

Details last updated 05-Mar-2023

Articles written by Kate Goodwin

Chroma secures new investment of 135M for Series B in genetic medicines

Chroma secures new investment of 135M for Series B in genetic medicines

Biospace - 01-Mar-2023

Epigenetic medicine approach avoids the pitfalls of traditional CRISPR method of gene editing